BIO
NYSEStockBio-Rad Laboratories, Inc.
$261.81-8.08 (-2.99%)
52-Week Range
$216.56
$339.75
Key Stats
Market Cap
7.1B
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.20
Volume
232.6K
Avg Volume
280.7K
Performance
1M
-12.72%
3M
-15.03%
6M
-6.56%
YTD
-14.23%
1Y
+4.25%
3Y
-46.43%
5Y
-54.03%
Price Chart
ETF Exposure
BIO is held by 163 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| GERM | ETFMG Treatments, Testing and Advancements ETF | 4.74% |
| KONG | Formidable Fortress ETF | 2.06% |
| MDEV | First Trust Indxx Medical Devices ETF | 1.84% |
| SAEF | Schwab Ariel ESG ETF | 1.64% |
| EPSB | Harbor SMID Cap Core ETF (EPSB) | 1.36% |
| HTEC | ROBO Global Healthcare Technology and Innovation ETF | 1.30% |
| MOM | AGFiQ U.S. Market Neutral Momentum Fund | 1.26% |
| APXH | Two Roads Shared Trust - APEX HealthCare ETF | 1.26% |
| EPMB | Harbor Mid Cap Core ETF (EPMB) | 1.11% |
| GOAT | VanEck Vectors Morningstar Global Wide Moat ETF | 1.04% |
| HEAL.L | iShares Healthcare Innovation UCITS ETF | 0.68% |
| JMIN | JPMorgan U.S. Minimum Volatility ETF | 0.56% |
| JHMH | John Hancock Multifactor Health Care ETF | 0.55% |
| DFSV | Dimensional - US Small Cap Value ETF | 0.43% |
| RVRS | Arrow Reverse Cap 500 ETF | 0.37% |
| PQLC | PGIM ETF Trust - PGIM QMA Strategic Alpha Large-Cap Core ETF | 0.33% |
| RBUS | Nationwide Risk-Based U.S. Equity ETF | 0.32% |
| HELX | Franklin Genomic Advancements ETF | 0.28% |
| BSCW | Invesco BulletShares 2032 Corporate Bond ETF | 0.27% |
| DFAT | Dimensional - US Targeted Value ETF | 0.27% |
| DFAS | Dimensional - US Small Cap ETF | 0.24% |
| USVM | VictoryShares US Small Mid Cap Value Momentum ETF | 0.24% |
| MIDE | Xtrackers S&P MidCap 400 Scored & Screened ETF | 0.23% |
| BLES | Inspire Global Hope ETF | 0.21% |
| OPTZ | Optimize Strategy Index ETF | 0.21% |
| NXTV | Simplify NEXT Intangible Value Index ETF | 0.19% |
| FSMD | FIDELITY SMALL-MID MULTIFACTOR ETF | 0.18% |
| FNDA | Schwab Fundamental U.S. Small Company Index ETF | 0.17% |
| QVMM | Invesco S&P MidCap 400 QVM Multi-factor ETF | 0.17% |
| IVOG | Vanguard S&P Mid-Cap 400 Growth ETF | 0.17% |
| PTMC | Pacer Trendpilot US Mid Cap ETF | 0.17% |
| XJH | iShares ESG Select Screened S&P Mid-Cap ETF | 0.17% |
| IVOO | Vanguard S&P Mid-Cap 400 ETF | 0.16% |
| FTLB | First Trust Nasdaq BuyWrite Income ETF | 0.16% |
| MDYG | State Street SPDR S&P 400 Mid Cap Growth ETF | 0.15% |
| IJK | iShares S&P Mid-Cap 400 Growth ETF | 0.15% |
| IVOV | Vanguard S&P Mid-Cap 400 Value ETF | 0.15% |
| IJH | iShares Core S&P Mid-Cap ETF | 0.15% |
| SPMD | State Street SPDR Portfolio S&P 400 Mid Cap ETF | 0.15% |
| MDY | State Street SPDR S&P MIDCAP 400 ETF Trust | 0.15% |
| IJJ | iShares S&P Mid-Cap 400 Value ETF | 0.14% |
| MDYV | State Street SPDR S&P 400 Mid Cap Value ETF | 0.14% |
| STXM | Strive Mid-Cap ETF | 0.14% |
| VBR | Vanguard Small-Cap Value ETF | 0.13% |
| BKMC | BNY Mellon US Mid Cap Core Equity ETF | 0.12% |
| EZM | WisdomTree U.S. MidCap Fund | 0.12% |
| ISCG | iShares Morningstar Small-Cap Growth ETF | 0.12% |
| JKK | iShares Morningstar Small-Cap Growth ETF | 0.12% |
| MVV | ProShares - Ultra MidCap400 | 0.12% |
| BBMC | JPMorgan BetaBuilders U.S. Mid Cap Equity ETF | 0.11% |
Page 1 of 4Next
About BIO ETF Exposure
Bio-Rad Laboratories, Inc. (BIO) is held by 163 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 7.1B, BIO is a widely held institutional stock. The stock currently trades at $261.81. Investors can gain exposure to BIO through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold BIO, sorted by portfolio weight.